Shenzhen YHLO Biotech Co., Ltd.
Industry Group: Healthcare
Country/Region: China
Identifier: SHG:688575
Shenzhen YHLO Biotech Co Ltd is an innovative enterprise focusing on overall clinical laboratory solutions with leading domestic technology and integrated research, production and marketing. Its main business is research and development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Healthcare 562 out of 588
Universe
Global Universe 12698 out of 15080
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Integra LifeSciences Holdings Corp. |
22.8
Medium
|
228 out of 588 |
Nakanishi, Inc. |
24.5
Medium
|
269 out of 588 |
Fukuda Denshi Co., Ltd. |
30.6
High
|
427 out of 588 |
Shenzhen YHLO Biotech Co., Ltd. |
35
High
|
562 out of 588 |
Shanghai Runda Medical Technology Co., Ltd. |
37.3
High
|
580 out of 588 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Shenzhen YHLO Biotech Co., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Shenzhen YHLO Biotech Co., Ltd.'s Management of ESG Material Risk is Average